Key result
Endothelial FGF-2 and IL-6 drive ~2-fold greater pulmonary artery pericyte coverage, worsening vascular remodeling.
Why the study?
Pulmonary endothelial dysfunction characterized by abnormal fibroblast growth factor-2 and interleukin-6 signaling may lead to abnormal microvascular pericyte coverage causing pulmonary arterial medial thickening in PAH.
Excessive pericyte coverage in distal pulmonary arteries, mediated by endothelial-derived FGF-2 and IL-6, contributes to pulmonary vascular remodeling in pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
May implicate pericyte-endothelial dysfunction in PAH; leaves open whether FGF-2/IL-6 targeting alters clinical outcomes.
BACKGROUND: Pericytes and their crosstalk with endothelial cells are critical for the development of a functional microvasculature and vascular remodeling. It is also known that pulmonary endothelial dysfunction is intertwined with the initiation and progression of pulmonary arterial hypertension (PAH). We hypothesized that pulmonary endothelial dysfunction, characterized by abnormal fibroblast growth factor-2 and interleukin-6 signaling, leads to abnormal microvascular pericyte coverage causing pulmonary arterial medial thickening. METHODS AND RESULTS: In human lung tissues, numbers of pericytes are substantially increased (up to 2-fold) in distal PAH pulmonary arteries compared with controls. Interestingly, human pulmonary pericytes exhibit, in vitro, an accentuated proliferative and migratory response to conditioned media from human idiopathic PAH endothelial cells compared with conditioned media from control cells. Importantly, by using an anti-fibroblast growth factor-2 neutralizing antibody, we attenuated these proliferative and migratory responses, whereas by using an anti-interleukin-6 neutralizing antibody, we decreased the migratory response without affecting the proliferative response. Furthermore, in our murine retinal angiogenesis model, both fibroblast growth factor-2 and interleukin-6 administration increased pericyte coverage. Finally, using idiopathic PAH human and NG2DsRedBAC mouse lung tissues, we demonstrated that this increased pericyte coverage contributes to pulmonary vascular remodeling as a source of smooth muscle-like cells. Furthermore, we found that transforming growth factor-β, in contrast to fibroblast growth factor-2 and interleukin-6, promotes human pulmonary pericyte differentiation into contractile smooth muscle-like cells. CONCLUSIONS: To the best of our knowledge, this is the first report of excessive pericyte coverage in distal pulmonary arteries in human PAH. We also show that this phenomenon is directly linked with pulmonary endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Ricard et al. (2014) studied Pulmonary Arterial Hypertension. Fibroblast growth factor-2 and interleukin-6 signaling vs. Control cells/tissues was evaluated on Pericyte coverage and pulmonary arterial medial thickening. Endothelial-derived fibroblast growth factor-2 and interleukin-6 increased pericyte coverage up to 2-fold in distal pulmonary arteries, contributing to pulmonary vascular remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: